Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsInventoryLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

LENZ Therapeutics (LENZ) Treasury Shares (2022 - 2025)

LENZ Therapeutics (LENZ) has disclosed Treasury Shares for 3 consecutive years, with $27640.0 as the latest value for Q4 2025.

  • Quarterly Treasury Shares changed N/A to $27640.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $27640.0 through Dec 2025, changed N/A year-over-year, with the annual reading at $27640.0 for FY2025, N/A changed from the prior year.
  • Treasury Shares for Q4 2025 was $27640.0 at LENZ Therapeutics, down from $152694.0 in the prior quarter.
  • The five-year high for Treasury Shares was $152694.0 in Q2 2023, with the low at $27640.0 in Q4 2025.
  • Average Treasury Shares over 3 years is $102975.8, with a median of $115784.5 recorded in 2022.
  • Peak annual rise in Treasury Shares hit 93.59% in 2023, while the deepest fall reached 93.59% in 2023.
  • Over 3 years, Treasury Shares stood at $78875.0 in 2022, then surged by 93.59% to $152694.0 in 2023, then tumbled by 81.9% to $27640.0 in 2025.
  • According to Business Quant data, Treasury Shares over the past three periods came in at $27640.0, $152694.0, and $152694.0 for Q4 2025, Q3 2023, and Q2 2023 respectively.